Bayer shares up after first trial win over Roundup By Reuters
BERLIN (Reuters), – Shares in Bayer AG The German agricultural and pharmaceuticals company, Roundup, won its first court case against it. This was Wednesday’s 2.5% increase in pre-market trade.
On Tuesday, a California jury found Roundup was not responsible for a rare form of nonHodgkin’s Lymphoma. Roundup’s fourth verdict was in its favor, and it is also the first to be ruled against.
Bayer has been plagued by Roundup lawsuits since the acquisition of the brand in connection with its purchase of pesticides and seeds maker, $63 billion. Monsanto In 2018, (NYSE:
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.